CXCL3 and prostate carcinoma: CXCL3 has been shown to act as a chemoattractant for neutrophils to areas of brain injury (35) and for cerebellar progenitor cells (36) , while it is not clear for prostate cancer cells if this chemokine is chemoattractant or not (32).